251 related articles for article (PubMed ID: 15071721)
1. Both corticotropin-releasing factor receptor type 1 and type 2 are involved in stress-induced inhibition of food intake in rats.
Sekino A; Ohata H; Mano-Otagiri A; Arai K; Shibasaki T
Psychopharmacology (Berl); 2004 Oct; 176(1):30-8. PubMed ID: 15071721
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing factor receptor type 1 mediates emotional stress-induced inhibition of food intake and behavioral changes in rats.
Hotta M; Shibasaki T; Arai K; Demura H
Brain Res; 1999 Mar; 823(1-2):221-5. PubMed ID: 10095032
[TBL] [Abstract][Full Text] [Related]
3. Sexual differentiation of the effects of emotional stress on food intake in rats.
Kuriyama H; Shibasaki T
Neuroscience; 2004; 124(2):459-65. PubMed ID: 14980395
[TBL] [Abstract][Full Text] [Related]
4. Effect of chronic administration of a CRF(1) receptor antagonist, CRA1000, on locomotor activity and endocrine responses to stress.
Ohata H; Arai K; Shibasaki T
Eur J Pharmacol; 2002 Dec; 457(2-3):201-6. PubMed ID: 12464367
[TBL] [Abstract][Full Text] [Related]
5. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Nakazato A; Kumagai T; Okubo T; Tomisawa K
J Pharmacol Exp Ther; 1999 May; 289(2):926-35. PubMed ID: 10215672
[TBL] [Abstract][Full Text] [Related]
6. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
[TBL] [Abstract][Full Text] [Related]
7. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
Oliveira LA; Almeida J; Benini R; Crestani CC
Pharmacol Res; 2015; 95-96():53-62. PubMed ID: 25829333
[TBL] [Abstract][Full Text] [Related]
8. Corticotropin-releasing factor as well as opioid and dopamine are involved in tail-pinch-induced food intake of rats.
Samarghandian S; Ohata H; Yamauchi N; Shibasaki T
Neuroscience; 2003; 116(2):519-24. PubMed ID: 12559107
[TBL] [Abstract][Full Text] [Related]
9. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
[TBL] [Abstract][Full Text] [Related]
10. Involvement of CRF2 receptor in the brain regions in restraint-induced anorexia.
Ohata H; Shibasaki T
Neuroreport; 2011 Jul; 22(10):494-8. PubMed ID: 21666520
[TBL] [Abstract][Full Text] [Related]
11. Corticotropin-releasing factor (CRF) receptor subtypes in mediating neuronal activation of brain areas involved in responses to intracerebroventricular CRF and stress in rats.
Takahashi C; Ohata H; Shibasaki T
Peptides; 2011 Dec; 32(12):2384-93. PubMed ID: 21964377
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.
Risbrough VB; Hauger RL; Roberts AL; Vale WW; Geyer MA
J Neurosci; 2004 Jul; 24(29):6545-52. PubMed ID: 15269266
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse.
Bruijnzeel AW; Prado M; Isaac S
Biol Psychiatry; 2009 Jul; 66(2):110-7. PubMed ID: 19217073
[TBL] [Abstract][Full Text] [Related]
14. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
Miguel TT; Nunes-de-Souza RL
Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
[TBL] [Abstract][Full Text] [Related]
15. Central CRF, urocortins and stress increase colonic transit via CRF1 receptors while activation of CRF2 receptors delays gastric transit in mice.
Martínez V; Wang L; Rivier J; Grigoriadis D; Taché Y
J Physiol; 2004 Apr; 556(Pt 1):221-34. PubMed ID: 14755002
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala.
Ji G; Neugebauer V
J Neurophysiol; 2007 Jun; 97(6):3893-904. PubMed ID: 17392412
[TBL] [Abstract][Full Text] [Related]
17. [Effect of corticotropin releasing factor(CRF) on somatic pain sensitivity in conscious rats: involvement of CRF1 and CRF2 receptors].
Iarushkina NI; Bagaeva TR; Filaretova LP
Ross Fiziol Zh Im I M Sechenova; 2014 Nov; 100(11):1287-96. PubMed ID: 25665407
[TBL] [Abstract][Full Text] [Related]
18. In vitro pharmacological profile of nonpeptide CRF1 receptor antagonists, CRA1000 and CRA1001.
Chaki S; Okuyama S; Nakazato A; Kumagai T; Okubo T; Ikeda Y; Oshida Y; Hamajima Y; Tomisawa K
Eur J Pharmacol; 1999 Apr; 371(2-3):205-11. PubMed ID: 10357258
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of corticotropin-releasing factor CRF
Ferrer-Pérez C; Reguilón MD; Manzanedo C; Aguilar MA; Miñarro J; Rodríguez-Arias M
Eur J Pharmacol; 2018 Mar; 823():87-95. PubMed ID: 29391155
[TBL] [Abstract][Full Text] [Related]
20. Antagonism of corticotrophin-releasing factor receptors in the fourth ventricle modifies responses to mild but not restraint stress.
Miragaya JR; Harris RB
Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R404-16. PubMed ID: 18550868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
